Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Multi-Omics Detection in Oligometastatic Colorectal Cancer Conversion Therapy
NCT07492238Active, not recruiting
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Open-label trial in colorectal cancer (CRC) (2 arms). Primary endpoint: Progression-Free Survival at 24 months. Started Mar 2025; status: active, not recruiting.
02
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07492238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07492238.